FDA has cleared Spectranetics’ new line of devices designed to treat clogged leg arteries. The Turbo elite products will be launched in limited release during the fourth quarter, and fully released in early 2007.
The devices are used in conjunction with the company’s excimer laser system, which helps open clogged or obstructed arteries. Spectranetics, Colorado Springs, CO, is a manufacturers of lasers used to treat heart conditions.
March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...
March 20, 2024 
February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...
February 12, 2024 
November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...
November 10, 2023 
October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...
October 24, 2023 
September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...
September 14, 2023 
July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...
July 11, 2023 
June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...
June 21, 2023 
June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...
June 16, 2023 
June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...
June 15, 2023 
March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...
March 08, 2023